Here at The Pathologist, we like to think that we offer a platform for laboratory medicine professionals to have important conversations. That has happened many times within our pages – from the merits of prostate-specific antigen testing to assays for PD-L1 testing. Now, the focus turns to autopsy requirements for residents; click here for Michael Multan’s original letter and read an important response below. And, if you want to start – or join in on – a conversation of your own, never hesitate to get in touch!

Yours, Michael Schubert, Editor

 
PROFESSION
Are Pathologists Happy?
04/30/2021 | Olivia Gaskill
Burned out and depressed or happy and healthy? We report the findings from the Medscape Pathologist Lifestyle, Happiness, and Burnout Report 2021
GUIDELINES AND RECOMMENDATIONS
Diagnostic Error: Common, Catastrophic, and Costly
04/28/2021 | Paul Epner
Examining the pitfalls of the healthcare system that pave the way for diagnostic error
FORENSICS
A Comment on Investigating Death
04/29/2021 | Rebecca Johnson
Rebecca Johnson of the American Board of Pathology responds to Michael Multan’s article, “On Investigating Death”
GENETICS AND EPIGENETICS
Weighing Up the Genetic Risk of Lung Cancer
04/27/2021 | Olivia Gaskill
Whole exome sequencing and endogenous DNA damage assays uncover deleterious germline variants associated with lung cancer susceptibility
 
One Year On

Listen to our expert roundtable on the current state of the COVID-19 pandemic, what we’ve learned so far, and the outlook for the future.

Image of the Week

Jigglypuff isn’t the first Pokémon to make an appearance in histology slides, but it sure is the most likely resemblance! Check out the full image at @iheartpath.

 
Webinars
Free webinar series – automation of in vitro drug testing

Learn from peers how benchtop instruments or automated workstations can be used for drug testing on 2D or 3D cell culture to enhance efficiency and productivity in the lab. Register now

How to drive in-house precision oncology testing into clinical practice

Register now for The Every Lab Summit, a free virtual event on May 20th exploring how any lab, anywhere, of any size can offer precision oncology NGS testing in-house to advance community cancer care.

Profiling cancer: Understanding genetic risk and the tumor-immune microenvironment

In this Journal Highlights double bill virtual event, we invite the authors of two recent publications to discuss their work in colorectal cancer (11 May) and breast cancer (12 May) using Fluidigm technology.

 
Application Note
Quantification of a corticosteriod and antibiotics in plasma

This application describes the analysis of the corticosteroid Dexamethasone and the antibiotics Tazobactam, Meropenem and Piperacillin.
Read App Note

 
Product Profile
dRASTTM Rapid Antimicrobial Susceptibility Testing for Sepsis patients

dRASTTM provides optimal antimicrobial therapy in as low as 4 hours on positive blood cultures. Fully automated, multi-sample & easy to use, dRASTTM is the solution for helping sepsis patients faster.
Read more

 
Special Promotions
The Pathologist Educator - taking the effort out of staying informed

Your one-stop shop for challenging cases, fun quizzes, educational content, and an array of professional development resources to suit your learning needs. Sign me up now!

We Bring Vision To Whole Slide Image Management.

Aurora mScope Image Management Solutions software suites specifically developed for Pathologists, Researchers, and Educators to easily manage, analyze, and share whole slide imagery across the web.
Read more

Discover the Innovators – Advanced Solutions for Your Laboratory

Are you in search of the next step in your lab’s evolution? Look no further – industry leaders in pathology and laboratory medicine showcase their latest solutions in our
2020 Innovators section!

 
Discover Great Events

We work with event organizers from all around the world to help bring the pathology community together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and stay up-to-date with the latest developments. 

Show me more